EBGene trial: Patient pre‐selection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
Gaucher, S., Lwin, S.M., Titeux, M., Abdul‐Wahab, A., Pironon, N., Izmiryan, A., Miskinyte, S., Ganier, C., Duchatelet, S., Mellerio, J.E., Bourrat, E., McGrath, J.A., Hovnanian, A.Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.18559
Date:
September, 2019
File:
PDF, 3.00 MB
2019